Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors

Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors

US Patent 6825354 · Granted Nov 30, 2004

Estimated economic value: $91,412,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GIP receptor agonist peptide compounds and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2023
Tripartite modulators of endosomal G protein-coupled receptors2022
Inhibitors of the kynurenine pathway2019
Triazine compounds as PI3 kinase and mTOR inhibitors2018
Inhibitors of the kynurenine pathway2017
Triazine compounds as PI3 kinase and MTOR inhibitors2015
Antiviral phosphonate analogs2015
Antiviral phosphonate analogs2014
Triazine compounds as PI3 kinase and mTOR inhibitors2014
Triazine compounds as P13 kinase and MTOR inhibitors2014